Related Experiment Video
Updated: Aug 11, 2026

Examination of Thymic Positive and Negative Selection by Flow Cytometry
Published on: October 8, 2012
Tumor necrosis factor-related apoptosis-inducing ligand in T cell development: sensitivity of human thymocytes
A K Simon1, O Williams, J Mongkolsapaya
1Medical Research Council Human Immunology Unit, Institute of Molecular Medicine, John Radcliffe Hospital, Headington, Oxford OX3 9DS, United Kingdom. katja.simon@ndm.ox.ac.uk
Abstract:
TRAIL (tumor necrosis factor-related apoptosis-inducing ligand) is a recently identified member of the tumor necrosis factor cytokine superfamily. TRAIL has been shown to induce apoptosis in various tumor cell lines, whereas most primary cells seem to be resistant. These observations have raised considerable interest in the use of TRAIL in tumor therapy. Yet little is known about the physiological function of TRAIL. This is particularly the case in the immune system, where TRAIL has been suggested by some to be involved in target cell killing and lymphocyte death. We have developed a panel of mAbs and soluble proteins to address the role of TRAIL in lymphocyte development. These studies demonstrate activation-induced sensitization of thymocytes to TRAIL-mediated apoptosis and expression of the apoptosis-inducing TRAIL receptors. However, with the use of several model systems, our subsequent experiments rule out the possibility that TRAIL plays a major role in antigen-induced deletion of thymocytes. In contrast to thymocytes, there is no up-regulation of TRAIL receptors in peripheral T cells on activation, which remain resistant to TRAIL. Thus, susceptibility to TRAIL-induced apoptosis is controlled differently by central and peripheral T cells.
Insights
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces apoptosis in tumor cells but not most primary cells. This study shows TRAIL resistance in peripheral T cells, unlike thymocytes, suggesting differential control in the immune system.
Area of Science:
- Immunology
- Cell Biology
- Molecular Biology
Background:
- Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces apoptosis in tumor cells but not most primary cells, making it a potential cancer therapeutic.
- The precise physiological role of TRAIL, particularly within the immune system, remains largely undefined.
- TRAIL's involvement in target cell killing and lymphocyte death has been proposed but requires further investigation.
Purpose of the Study:
- To investigate the role of TRAIL in lymphocyte development and function.
- To determine the susceptibility of thymocytes and peripheral T cells to TRAIL-mediated apoptosis.
- To elucidate the regulation of TRAIL receptor expression in different T cell populations.
Main Methods:
- Development of a panel of monoclonal antibodies (mAbs) and soluble proteins targeting TRAIL.
- Analysis of TRAIL receptor expression and apoptosis induction in thymocytes and peripheral T cells.
- Utilizing various model systems to assess TRAIL's role in T cell activation and deletion.
Main Results:
- Thymocytes exhibit activation-induced sensitization to TRAIL-mediated apoptosis, with corresponding upregulation of TRAIL receptors.
- TRAIL does not appear to play a significant role in antigen-induced deletion of thymocytes.
- Activated peripheral T cells do not upregulate TRAIL receptors and remain resistant to TRAIL-induced apoptosis.
Conclusions:
- Susceptibility to TRAIL-induced apoptosis is differentially regulated in central (thymocytes) and peripheral T cells.
- TRAIL's role in the immune system is complex and varies depending on the T cell subset and activation status.
- These findings highlight distinct mechanisms controlling TRAIL sensitivity in different immune compartments.
Related Concept Videos
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...

